Lipid-based transfection is a powerful and widely adopted approach for delivering nucleic acids into mammalian cells. Yet many adherent cell lines remain notoriously difficult to transfect, limiting efficiency and reproducibility. EZ-Fect™ overcomes this challenge.Built on a next-generation lipid platform, EZ-Fect™ delivers higher expression, lower cytotoxicity, and consistent performance—even in cells where conventional reagents fall short. How EZ-Fect™ Works EZ-Fect™ employs a three-step, precision-engineered formulation to optimize every stage of nucleic acid delivery: Tube 1 — Optimized Lipoplex FormationA proprietary lipid blend forms uniformly sized lipoplexes for efficient plasma membrane fusion. Tube 2 — Nuclear Transport EnhancementA unique enhancer promotes transport of nucleic acids across the nuclear envelope. (Optional) Tube 3 — Stabilized Nucleic Acid in Cytoplasm A specialized cocktail reduces nucleic acid degradation in cell lines with strong DNA sensing/degradation pathways. Together, these synergistic components enable robust, reproducible transfection in historically difficult-to-transfect adherent cell types—outperforming leading lipid-based alternatives. Blow are representative transfection results across 3 historically highly challenging cell lines (L929, A431, BJ) along with a positive control cell line A549: